## **Core Concept**
The management of hyperthyroidism during pregnancy requires careful consideration to ensure the health of both the mother and the fetus. Antithyroid drugs are a common treatment approach, and the choice among them depends on their safety profile and efficacy during pregnancy.

## **Why the Correct Answer is Right**
Propylthiouracil (PTU) is often considered the antithyroid drug of choice during the first trimester of pregnancy due to its lower risk of teratogenicity compared to methimazole. Methimazole has been associated with congenital anomalies, such as esophageal atresia and choanal atresia, whereas PTU is less likely to cause these issues. However, due to the risk of hepatotoxicity associated with PTU, methimazole is sometimes preferred during the second and third trimesters. The American Thyroid Association recommends PTU during the first trimester, switching to methimazole if needed later in pregnancy.

## **Why Each Wrong Option is Incorrect**
* **Option A:** Methimazole, although effective, carries a higher risk of congenital anomalies compared to PTU, making it less ideal during the first trimester.
* **Option B:** This option is not provided, but typically, other antithyroid drugs like radioactive iodine are contraindicated in pregnancy due to the risk of thyroid ablation in the fetus.
* **Option D:** Beta blockers may be used to manage symptoms of hyperthyroidism but are not a primary treatment for hyperthyroidism itself and do not affect thyroid hormone production.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that the management of hyperthyroidism in pregnancy often involves a switch from PTU to methimazole after the first trimester due to the risk of PTU-induced hepatotoxicity. Monitoring liver function tests is crucial when using PTU.

## **Correct Answer:** .